1. The association between codon72 polymorphism of p53 gene and the risk of endometrial cancer: an updating meta-analysis
   Xinzi Lin et al, 2016, Arch Gynecol Obstet CrossRef
2. TP53 Arg72Pro polymorphism (rs1042522) and risk of endometriosis among Asian and Caucasian populations.
   J Li et al, 2015, Eur J Obstet Gynecol Reprod Biol CrossRef
3. Trends of SHBG and ABP levels in male farmers: Influences of environmental fluoride exposure and ESR alpha gene polymorphisms
   Ning An et al, 2019, Ecotoxicology and Environmental Safety CrossRef
4. Evaluation of the p53 Arg72Pro polymorphism and its association with cancer risk: a HuGE review and meta-analysis
   MOHAMMAD HAROON KHAN et al, 2015, Genet. Res. CrossRef
5. MDM2 rs2279744 polymorphism and endometrial cancer: a meta-analysis
   Li-Hong Wang et al, 2014, Tumor Biol. CrossRef
6. Association between p53 codon 72 polymorphism and sarcoma risk among Caucasians
   Zhengqi Chang et al, 2014, Tumor Biol. CrossRef
7. Common variant on MDM2 contributes to endometrial cancer susceptibility: evidence based on 7 studies
   Yan Zhao et al, 2014, Tumor Biol. CrossRef
8. TP53 and MDM2 polymorphisms and the risk of endometrial cancer in postmenopausal women
   Agnieszka Zając et al, 2014, Med Oncol CrossRef
9. SNP55, a new functional polymorphism of MDM2-P2 promoter, contributes to allele-specific expression of MDM2 in endometrial cancers
   Kanako Okamoto et al, 2015, BMC Med Genet CrossRef
10. The Association Between p53 Codon 72 Polymorphism and Endometrial Cancer Risk: A System Review and Meta-analysis
    Ke Yi et al, 2016, Int J Gynecol Cancer CrossRef
11. Relationship Between Murine Double Minute 2 (MDM2) T309G Polymorphism and Endometrial Cancer Risk: A Meta-Analysis
    Zhuowei Xue et al, 2016, Med Sci Monit CrossRef
12. Impact of TP53 polymorphisms (IVS3 + 40-41ins16, EX4 215G > C and IVS6 + 62G > A) on the risk of endometrial cancer, survival and hazard ratio of the patients
    Srivani L.S.S. Nagam et al, 2020, Meta Gene CrossRef
13. CP‑31398 attenuates endometrial cancer cell invasion, metastasis and resistance to apoptosis by downregulating MDM2 expression
    Ling Liu et al, 2019, Int J Oncol CrossRef
14. Association between genetic polymorphisms and endometrial cancer risk: a systematic review
    Cemsel Bafligil et al, 2020, J Med Genet CrossRef
15. Ninjurin 2 rs118050317 gene polymorphism and endometrial cancer risk
    Yimin Cheng et al, 2021, Cancer Cell Int CrossRef
16. MDM2 SNP309 polymorphism contributes to endometrial cancer susceptibility: evidence from a meta-analysis
    Qiliu Peng et al, 2013, J Exp Clin Cancer Res CrossRef
17. P53 Codon 72 and Endometrium Cancer
    null F. Gloria-Bottini et al, 2015, J. Can. Res. Updates CrossRef
18. UBE2J1 knockdown promotes cell apoptosis in endometrial cancer via regulating PI3K/AKT and MDM2/p53 signaling
    Ping Zhang et al, 2023 CrossRef
19. Association between MDM2 SNP309 and endometrial cancer risk
    Xinwei Zou et al, 2018 CrossRef